Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Mosunetuzumab
Non-Hodgkin Lymphoma
Bristol-Myers SquibbP3BB (68)
Nivolumab
Brain Neoplasm
InSightecP3BB (68)
Nivolumab
Cutaneous Melanoma
Fred Hutchinson Cancer CenterP3BB (68)
Nivolumab
Clinical Stage IV Cutaneous Melanoma AJCC v8
Fred Hutchinson Cancer CenterP3BB (68)
Nivolumab
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)P3BB (68)
Nivolumab
Ureter Transitional Cell Carcinoma
Alliance for Clinical Trials in OncologyP3BB (68)
Obinutuzumab
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (68)
PANITUMUMAB
Colorectal Cancer
MSPU des 3 ProvincesP3BB (68)
Pembrolizumab
Hepatocellular Carcinoma
Fudan UniversityP3BB (68)
Pembrolizumab
Metastatic Bladder Urothelial Carcinoma
Fred Hutchinson Cancer CenterP3BB (68)
Pembrolizumab
Recurrent Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP3BB (68)
Serplulimab
Non Small Cell Lung Cancer
Tang-Du HospitalP3BB (68)
Serplulimab
Small Cell Lung Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,LtdP3BB (68)
TRASTUZUMAB
Breast Disorder
Incepta Pharmaceuticals LtdP3BB (68)
TRASTUZUMAB
Breast Neoplasm
Merck Sharp & Dohme LLCP3BB (68)
TRASTUZUMAB
Colon Carcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (68)
TRASTUZUMAB
Invasive Breast Carcinoma
Massachusetts General HospitalP3BB (68)
TRASTUZUMAB
Stage III Colon Cancer
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (68)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Recurrent Rectal Carcinoma
SWOG Cancer Research NetworkP2BB (68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHDP2BB (68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
HIV Infectious Disease
City of Hope Medical CenterP2BB (68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoma, T-Cell
Memorial Sloan Kettering Cancer CenterP2BB (68)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Malignant Pancreatic Neoplasm
Baki TopalP2BB (68)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Plasma Cell Myeloma
SanofiP2BB (68)
Ipilimumab
Recurrent Hodgkin Lymphoma
Dana-Farber Cancer InstituteP2BB (68)
Showing 151 to 175 of 6,371 assets
PreviousPage 7 of 255Next